This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (35)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ATHANASIOS THEOLOGIDES, MD; B. J. KENNEDY, MD

Arch Intern Med. 1966;117(4):536-540.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

UNUSUAL NUSUAL protozoan, fungal, and viral infections have been reported during the use of corticosteroids and other immunosuppressive agents in the treatment of autoimmune and malignant diseases. The occurrence of toxoplasmosis during our study of advanced cancer prompted a review of the clinical manifestations of this disease. As a result a modified classification of toxoplasmosis in the adult is proposed.

The protozoan, Toxoplasma gondii, may produce a congenital or an acquired disease. The congenital type is usually recognized at birth or very early in life and may remain dormant or may progress.¹ In the inactive congenital cases the stigmata of the disease are present in later years. Some cases with systemic manifestations in the adult may represent a previously dormant congenital disease in relapse,² such as a late relapse of congenital ocular toxoplasmosis.^3,4 Acquired toxoplasmosis may have minimal symptoms ⁵ or be completely asymptomatic; the latter is . . . [Full Text PDF of this Article]

Author Affiliations
MINNEAPOLIS

From the Department of Medicine, University of Minnesota Medical Center, Minneapolis.

Footnotes
Received for publication Dec 2, 1965; accepted Jan 11, 1966.

Reprint requests to Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minn 55417 (Dr. Theologides).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?